Arise AB (ARISE):企業の財務・戦略的SWOT分析

◆英語タイトル:Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2574
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:エネルギー
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Arise AB (ARISE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Arise AB (Arise) is an integrated onshore wind company. It involves in project development and sale of electricity generation through its onshore wind turbines. The company manages exploration, construction, sale, long-term management and financing of its own and third party wind farms. Arise owns wind plants in southern Sweden; and co-owns the Jadraas project, along with Platina Partners LLP. Through contractual agreements, it sells electricity to customers and in spot market. The company serves customers in Sweden and Norway. Arise is headquartered in Halmstad, Sweden.

Arise AB Key Recent Developments

Jul 20,2018: Arise AB exceeds 1000 MW in total managed wind power capacity
Jun 11,2018: Power production in May 29.7 GWh: Arise AB
May 09,2018: Power production in April 46.5 GWh: Arise AB
May 03,2018: Iinterim report 1 January-31 March 2018
Apr 09,2018: Power production in March 39.3 GWh: ARISE AB

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Arise AB – Key Facts 6
Arise AB – Key Employees 7
Arise AB – Key Employee Biographies 8
Arise AB – Key Operational Employees 9
Arise AB – Major Products and Services 10
Arise AB – History 11
Arise AB – Company Statement 13
Arise AB – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 17
Company Overview 17
Arise AB – Business Description 18
Business Segment: Co-owned Wind Power Operations 18
Overview 18
Performance 18
Key Stats 18
Business Segment: Development and Management 18
Overview 18
Performance 18
Business Segment: Own Wind Power Operations 18
Overview 18
Performance 19
Key Stats 19
Arise AB – SWOT Analysis 20
SWOT Analysis – Overview 20
Arise AB – Strengths 20
Arise AB – Weaknesses 21
Arise AB – Opportunities 22
Arise AB – Threats 23
Arise AB – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Power Financial Deals and Alliances 31
Arise AB, Power, Deals By Year, 2012 to YTD 2018 31
Arise AB, Power, Deals By Type, 2012 to YTD 2018 32
Arise AB, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Jul 20, 2018: Arise AB exceeds 1000 MW in total managed wind power capacity 34
Jun 11, 2018: Power production in May 29.7 GWh: Arise AB 35
May 09, 2018: Power production in April 46.5 GWh: Arise AB 36
May 03, 2018: Iinterim report 1 January-31 March 2018 37
Apr 09, 2018: Power production in March 39.3 GWh: ARISE AB 38
Mar 06, 2018: Power production in February 40.3 GWh: Arise AB 39
Feb 09, 2018: Power production in January 52.7 GWh: Arise 40
Jan 09, 2018: Power production in December 71.1 GWh 41
Jan 09, 2018: Power production in December 71.1 GWh 42
Nov 10, 2017: Interim report 1 January-30 September 2017: Arise AB 43
Section 6 – Appendix 46
Methodology 46
Ratio Definitions 46
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Arise AB, Key Facts 6
Arise AB, Key Employees 7
Arise AB, Key Employee Biographies 8
Arise AB, Key Operational Employees 9
Arise AB, Major Products and Services 10
Arise AB, History 11
Arise AB, Subsidiaries 16
Arise AB, Key Competitors 24
Arise AB, Ratios based on current share price 25
Arise AB, Annual Ratios 26
Arise AB, Annual Ratios (Cont...1) 27
Arise AB, Interim Ratios 29
Arise AB, Power, Deals By Year, 2012 to YTD 2018 31
Arise AB, Power, Deals By Type, 2012 to YTD 2018 32
Arise AB, Recent Deals Summary 33
Currency Codes 46
Capital Market Ratios 46
Equity Ratios 47
Profitability Ratios 47
Cost Ratios 48
Liquidity Ratios 48
Leverage Ratios 49
Efficiency Ratios 49

List of Figures
Arise AB, Performance Chart (2013 - 2017) 28
Arise AB, Ratio Charts 30
Arise AB, Power, Deals By Year, 2012 to YTD 2018 31
Arise AB, Power, Deals by Type, 2012 to YTD 2018 32

★海外企業調査レポート[Arise AB (ARISE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NWS Holdings Limited:企業の戦略・SWOT・財務情報
    NWS Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary NWS Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ajman Bank (AJMANBANK):企業の財務・戦略的SWOT分析
    Ajman Bank (AJMANBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Compania Espanola de Petroleos SAU:石油・ガス:M&Aディール及び事業提携情報
    Summary Compania Espanola de Petroleos SAU (CEPSA) is an integrated energy company. It explores for, produces, refines, transports, and markets and sells crude oil, petroleum products, and natural gas. The company also generates and sells electricity and thermal power to industrial customers and con …
  • Royal Orchid Hotels Ltd:企業の戦略・SWOT・財務分析
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Acorda Therapeutics Inc (ACOR)-製薬・医療分野:企業M&A・提携分析
    Summary Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. The company’s commercial products include Ampyra (dalfampridine), a treatment to improve walking in patients with multiple …
  • tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報
    Summary Tella Inc (Tella) is a drug development company that develops vaccines for cancer treatment. The company offers dendritic cell vaccine therapy which develops dendritic cells to convey the information on cancer markers to lymphocytes and increase the dendritic cell population and strengthen t …
  • Cogstate Ltd (CGS)-製薬・医療分野:企業M&A・提携分析
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …
  • BTB Real Estate Investment Trust:企業の戦略・SWOT・財務分析
    BTB Real Estate Investment Trust - Strategy, SWOT and Corporate Finance Report Summary BTB Real Estate Investment Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CGU Insurance Limited:企業の戦略・SWOT・財務情報
    CGU Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary CGU Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SOLX Inc:医療機器:M&Aディール及び事業提携情報
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • Eagle Bancorp Inc:企業の戦略・SWOT・財務分析
    Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Prairie Provident Resources Inc (PPR):石油・ガス:M&Aディール及び事業提携情報
    Summary Prairie Provident Resources Inc (Prairie Provident) is an exploration and development company that develops oil and natural gas assets. The company offers exploration and development of oil and natural gas with conventional operations primarily focused in the Western Canadian Sedimentary Bas …
  • Wellcome Trust Sanger Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research a …
  • Catalyst Biosciences Inc (CBIO):医療機器:M&Aディール及び事業提携情報
    Summary Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophil …
  • Vaccinex Inc (VCNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Therapure Biopharma Inc (Therapure) is a biotherapeutics company that enhances patient care through its three divisions: therapure biomanufacturing, therapure innovations and evolve biologics. The company's therapure biomanufacturing division offers pipeline products such as TBI 301, TBI 302 …
  • Gadeta BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Gadeta BV (Gadeta) is a biotechnology company, which focuses on the research and development of cellular immunotherapies for the elimination of cancer. The company’s technology platform combines alpha beta T cells engineered to express defined Gamma Delta T cell receptors (TEGs) that demonst …
  • The Cooper Companies, Inc.:企業の戦略・SWOT・財務情報
    The Cooper Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Cooper Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • TETRA Technologies Inc (TTI):企業の財務・戦略的SWOT分析
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology cen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆